Christopher Gallen

Christopher Gallen

Président chez
Treos Bio Ltd.
74 ans
Health Technology
Commercial Services
Consumer Services

Profil

Christopher C.
Gallen
is Chairman at Treos Bio Ltd. since 2026.
Former positions include President & Chief Executive Officer at Neuromed Pharmaceuticals, Inc. in 2010 and at Neuromed Pharmaceuticals Ltd. from 2004 to 2010; Senior Director-Medical & Scientific Services at Quintiles International Clinical Research Corp.
in 1995; Vice President-Research & Development at CombinatoRx, Inc. in 2010; President-Clinical Research Organization Division at Premier Research Worldwide in 1998; Chief of Operations & Clinical Research at Wyeth Research from 2002 to 2011; Vice President-Clinical Research at Pharmacia, Inc.; and Executive Vice President-Research & Development at Zalicus, Inc. from 2010 to 2012.
Education includes a doctorate from Emory University and an undergraduate degree from the University of Florida.

Postes actifs de Christopher Gallen

SociétésPosteDébut
Président 28/05/2026

Anciens postes connus de Christopher Gallen

SociétésPosteFin
Directeur Technique/Scientifique/R&D 01/03/2012
President 07/01/2010
President 27/01/2010
President 27/01/2010
Corporate Officer/Principal 01/12/1998
Voir l'expérience en détail de Christopher Gallen

Formation de Christopher Gallen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

19

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Pharmacia, Inc.

Health Technology

Quintiles International Clinical Research Corp.

Commercial Services

  1. Bourse
  2. Insiders
  3. Christopher Gallen
🔇